Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 7 (2010), Issue 5 (May)

1. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
   Ann Neurol, 67(4): 452-61. [Abstract] [Full-text]
2. Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials.
   Ann Neurol, 67(5): 667-75. [Abstract] [Full-text]
3. Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis.
   Ann Neurol, 67(5): 625-38. [Abstract] [Full-text]
4. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
   Ann Neurol, 67(5): 618-24. [Abstract] [Full-text]
5. Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis.
   J Biol Chem, 285(19): 14134-43. [Abstract] [Full-text]
6. In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique.
   Neuroimage, 51(3): 1089-97. [Abstract] [Full-text]
7. Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
   Neurology, 74(18): 1463-70. [Abstract] [Full-text]
8. Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response.
   Neurology, 74(18): 1455-62. [Abstract] [Full-text]
9. A comparison of MRI criteria for diagnosing pediatric ADEM and MS.
   Neurology, 74(18): 1412-5. [Abstract] [Full-text]
10. Glatiramer acetate for multiple sclerosis.
    Cochrane Database Syst Rev, 5: CD004678. [Abstract] [Full-text]
11. APOE epsilon4 and the cognitive genetics of multiple sclerosis.
    Neurology, 74(20): 1611-8. [Abstract] [Full-text]
12. Gender-specific expression of beta1 integrin of VLA-4 in myelin basic protein-primed T cells: implications for gender bias in multiple sclerosis.
    J Immunol, 184(11): 6103-13. [Abstract] [Full-text]
13. Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis.
    Clin Pharmacol Ther, 87(6): 679-85. [Abstract] [Full-text]
14. Cycling progressive resistance training for people with multiple sclerosis: a randomized controlled study.
    Am J Phys Med Rehabil, 89(6): 446-57. [Abstract] [Full-text]
15. Vitamin D and multiple sclerosis.
    Lancet Neurol, 9(6): 599-612. [Abstract] [Full-text]
16. Fatigue in multiple sclerosis: mechanisms and management.
    Clin Neurophysiol, 121(6): 809-17. [Abstract] [Full-text]
17. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole.
    Neurology, 74(21): 1694-701. [Abstract] [Full-text]
18. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis.
    Nat Genet, 42(6): 495-7. [Abstract] [Full-text]
19. T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis.
    Brain, 133: 1622-36. [Abstract] [Full-text]
20. Complement regulator factor H as a serum biomarker of multiple sclerosis disease state.
    Brain, 133: 1602-11. [Abstract] [Full-text]
21. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.
    Brain, 133: 1591-601. [Abstract] [Full-text]
22. Resting state networks change in clinically isolated syndrome.
    Brain, 133: 1612-21. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.